The field of oncology has experienced a significant wave of innovation in next generation of T-cell […]
In this episode of ClearView Convos, Sam Ulin is joined by Kelsey Yardumian and David Konciak […]
In today’s increasingly competitive landscape, biopharma manufacturers must strategically prepare for launch. ClearView spoke with 11 […]
Real talk on launch strategy— in this episode of ClearView Convos, @Jessica Lee and @Alex Lehrman […]
In this episode, Sam Ulin, Debbie Zhuang, and Matthew Murphy dive into the strategic heart of […]
Yesterday we recorded a follow-up to Episode 2, diving deeper into evolving vaccine dynamics after RFK […]
Episode 2 digs into the regulatory uncertainty in the vaccine world – what we know, what […]
Sam Ulin moderates a discussion with Pricing & Market Access Partners Mike Rizzo and Rishi Dalsania […]
An evolving vaccine market fueled by rapid innovation has shifted channels for vaccine distribution and administration, […]
As companies with global commercialization aspirations move from clinical development to launch, it becomes important to […]
BIO-Europe Spring connects Europe’s top innovation centers with the global life sciences industry to cultivate thriving […]
ClearView Healthcare Partners Makes Strategic Investment in Epistemic AI to Advance Next-Generation Biomedical AI Platform ClearView […]
From a population health perspective, the need to more effectively treat neurological dysfunction is pressing, as […]